Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ekso Bionics Holdings (EKSO) Depreciation & Amortization (CF) (2016 - 2025)

Ekso Bionics Holdings (EKSO) has disclosed Depreciation & Amortization (CF) for 13 consecutive years, with $451000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Depreciation & Amortization (CF) rose 13.32% to $451000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.6 million, a 2.18% decrease, with the full-year FY2025 number at $1.6 million, down 2.18% from a year prior.
  • Depreciation & Amortization (CF) was $451000.0 for Q4 2025 at Ekso Bionics Holdings, up from $367000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $451000.0 in Q4 2025 to a low of -$221000.0 in Q4 2021.
  • A 5-year average of $291350.0 and a median of $377500.0 in 2025 define the central range for Depreciation & Amortization (CF).
  • Peak YoY movement for Depreciation & Amortization (CF): plummeted 22200.0% in 2021, then surged 23000.0% in 2022.
  • Ekso Bionics Holdings' Depreciation & Amortization (CF) stood at -$221000.0 in 2021, then soared by 216.74% to $258000.0 in 2022, then soared by 67.44% to $432000.0 in 2023, then fell by 7.87% to $398000.0 in 2024, then grew by 13.32% to $451000.0 in 2025.
  • Per Business Quant, the three most recent readings for EKSO's Depreciation & Amortization (CF) are $451000.0 (Q4 2025), $367000.0 (Q3 2025), and $377000.0 (Q2 2025).